Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/20178580

Download in:

View as

General Info

PMID
20178580